Yeole Ujwal, Prabhuraj A R, Arivazhagan Arimappamagan, Narasingarao K V L, Vazhayil Vikas, Bhat Dhananjaya, Srinivas Dwarakanath, Govindswamy Bhanumathi, Sampath Somanna
Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Division of Radiation Oncology, Department of Neurosurgery, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
J Neurol Surg B Skull Base. 2021 May 23;83(Suppl 2):e343-e352. doi: 10.1055/s-0041-1729977. eCollection 2022 Jun.
Gamma Knife radiosurgery (GKRS) is an effective treatment for benign vestibular schwannomas (VSs). The established cutoffs have recently been challenged, as recent literature expanded the horizon of GKRS to larger tumors. Even though microsurgery remains the primary option for large VS, GKRS can provide reasonable tumor control and is more likely to avoid cranial neuropathies associated with open surgery. We analyzed patients with VS with volume exceeding 10 cm who underwent GKRS at our center from January 2006 to December 2016. Clinicoradiological and radiosurgical data were collected from medical records for statistical analysis. Follow-up was performed every 6 months with a clinical assessment along with magnetic resonance imaging (MRI) of the brain and audiometric evaluation in patients with serviceable hearing. The study included 34 patients (18 males and 16 females) with an average age of 45.5 years. The mean tumor volume was 10.9 cm (standard deviation [SD], ± 0.83), with a median tumor dose of 12 Gy (interquartile range, 11.5-12) and a mean follow-up of 34.7 months (SD, ± 23.8). Tumor response was graded as regression in 50%, stable in 44.1%, and increase or GKRS failure in 2 cases (5.8%). Treatment failure was noted in five cases (14.7%), requiring microsurgical excision and a ventriculoperitoneal shunt post-GKRS. The tumor control rate for the cohort is 85.3%, with a facial preservation rate of 96% (24/25) and hearing loss in all (5/5), while three patients developed new-onset hypoesthesia. We noted that gait ataxia and involvement of cranial nerve V or VII at initial presentation were associated with GKRS failure in univariate analysis. Microsurgery should remain the first-choice treatment option for large VSs. GKRS is a viable alternative with good tumor control and improved or stabilized cranial neuropathies with a low complication rate.
伽玛刀放射外科治疗(GKRS)是治疗良性前庭神经鞘瘤(VS)的一种有效方法。既定的肿瘤大小临界值最近受到了挑战,因为近期文献将GKRS的适用范围扩大到了更大的肿瘤。尽管显微手术仍是大型VS的主要治疗选择,但GKRS能实现合理的肿瘤控制,且更有可能避免与开放手术相关的颅神经病变。
我们分析了2006年1月至2016年12月期间在本中心接受GKRS治疗的VS体积超过10 cm³ 的患者。从病历中收集临床放射学和放射外科数据进行统计分析。每6个月进行一次随访,包括临床评估以及对有听力的患者进行脑部磁共振成像(MRI)和听力测定评估。
该研究纳入了34例患者(18例男性和16例女性),平均年龄45.5岁。平均肿瘤体积为10.9 cm³(标准差[SD],±0.83),中位肿瘤剂量为12 Gy(四分位间距,11.5 - 12),平均随访时间为34.7个月(SD,±23.8)。肿瘤反应分级为:50%呈消退,44.1%稳定,2例(5.8%)增大或GKRS治疗失败。5例(14.7%)出现治疗失败,需要在GKRS后进行显微手术切除和脑室腹腔分流术。该队列的肿瘤控制率为85.3%,面神经保留率为96%(24/25),所有有听力的患者(5/5)均出现听力丧失,3例患者出现新发感觉减退。我们注意到,在单因素分析中,初始表现为步态共济失调以及颅神经V或VII受累与GKRS治疗失败相关。
显微手术应仍然是大型VS的首选治疗方案。GKRS是一种可行的替代方案,具有良好的肿瘤控制效果,可改善或稳定颅神经病变,且并发症发生率低。